Association of Chemotherapy Timing in Pregnancy With Congenital Malformation

Mathilde van Gerwen; Charlotte Maggen; Elyce Cardonick; Emma J. Verwaaijen; Marry van den Heuvel-Eibrink; Roman G. Shmakov; Ingrid Boere; Mina M. Gziri; Petronella B. Ottevanger; Christianne A.R. Lok; Michael Halaska; Long Ting Shao; Ilana Struys; Elisabeth M. van Dijk-Lokkart; Kristel van Calsteren; Robert Fruscio; Paolo Zola; Giovanna Scarfone; Frédéric Amant

doi:10.1097/01.ogx.0000802680.45004.84

Association of Chemotherapy Timing in Pregnancy With Congenital Malformation

Mathilde van Gerwen, Charlotte Maggen, Elyce Cardonick, Emma J. Verwaaijen, Marry van den Heuvel-Eibrink, Roman G. Shmakov, Ingrid Boere, Mina M. Gziri, Petronella B. Ottevanger, Christianne A.R. Lok, Michael Halaska, Long Ting Shao, Ilana Struys, Elisabeth M. van Dijk-Lokkart, Kristel van Calsteren, Robert Fruscio, Paolo Zola, Giovanna Scarfone, Frédéric Amant

Medical Oncology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

Chemotherapy puts a developing fetus at risk of teratogenic effects. The standard recommendation is that chemotherapy be administered after organogenesis is complete, however, the exact gestational age that chemotherapy can be administered safely and avoid causing congenital malformations remains unknown.

Original language	English
Pages (from-to)	732-733
Number of pages	2
Journal	Obstetrical and Gynecological Survey
Volume	76
Issue number	12
DOIs	https://doi.org/10.1097/01.ogx.0000802680.45004.84
Publication status	Published - Dec 2021

Access to Document

10.1097/01.ogx.0000802680.45004.84

Cite this

van Gerwen, M., Maggen, C., Cardonick, E., Verwaaijen, E. J., van den Heuvel-Eibrink, M., Shmakov, R. G., Boere, I., Gziri, M. M., Ottevanger, P. B., Lok, C. A. R., Halaska, M., Shao, L. T., Struys, I., van Dijk-Lokkart, E. M., van Calsteren, K., Fruscio, R., Zola, P., Scarfone, G., & Amant, F. (2021). Association of Chemotherapy Timing in Pregnancy With Congenital Malformation. Obstetrical and Gynecological Survey, 76(12), 732-733. https://doi.org/10.1097/01.ogx.0000802680.45004.84

@article{885762b866034834aadca51c65c1e5b4,

title = "Association of Chemotherapy Timing in Pregnancy With Congenital Malformation",

abstract = "Chemotherapy puts a developing fetus at risk of teratogenic effects. The standard recommendation is that chemotherapy be administered after organogenesis is complete, however, the exact gestational age that chemotherapy can be administered safely and avoid causing congenital malformations remains unknown.",

author = "{van Gerwen}, Mathilde and Charlotte Maggen and Elyce Cardonick and Verwaaijen, {Emma J.} and {van den Heuvel-Eibrink}, Marry and Shmakov, {Roman G.} and Ingrid Boere and Gziri, {Mina M.} and Ottevanger, {Petronella B.} and Lok, {Christianne A.R.} and Michael Halaska and Shao, {Long Ting} and Ilana Struys and {van Dijk-Lokkart}, {Elisabeth M.} and {van Calsteren}, Kristel and Robert Fruscio and Paolo Zola and Giovanna Scarfone and Fr{\'e}d{\'e}ric Amant",

year = "2021",

month = dec,

doi = "10.1097/01.ogx.0000802680.45004.84",

language = "English",

volume = "76",

pages = "732--733",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams & Wilkins",

number = "12",

}

van Gerwen, M, Maggen, C, Cardonick, E, Verwaaijen, EJ, van den Heuvel-Eibrink, M, Shmakov, RG, Boere, I, Gziri, MM, Ottevanger, PB, Lok, CAR, Halaska, M, Shao, LT, Struys, I, van Dijk-Lokkart, EM, van Calsteren, K, Fruscio, R, Zola, P, Scarfone, G & Amant, F 2021, 'Association of Chemotherapy Timing in Pregnancy With Congenital Malformation', Obstetrical and Gynecological Survey, vol. 76, no. 12, pp. 732-733. https://doi.org/10.1097/01.ogx.0000802680.45004.84

TY - JOUR

T1 - Association of Chemotherapy Timing in Pregnancy With Congenital Malformation

AU - van Gerwen, Mathilde

AU - Maggen, Charlotte

AU - Cardonick, Elyce

AU - Verwaaijen, Emma J.

AU - van den Heuvel-Eibrink, Marry

AU - Shmakov, Roman G.

AU - Boere, Ingrid

AU - Gziri, Mina M.

AU - Ottevanger, Petronella B.

AU - Lok, Christianne A.R.

AU - Halaska, Michael

AU - Shao, Long Ting

AU - Struys, Ilana

AU - van Dijk-Lokkart, Elisabeth M.

AU - van Calsteren, Kristel

AU - Fruscio, Robert

AU - Zola, Paolo

AU - Scarfone, Giovanna

AU - Amant, Frédéric

PY - 2021/12

Y1 - 2021/12

N2 - Chemotherapy puts a developing fetus at risk of teratogenic effects. The standard recommendation is that chemotherapy be administered after organogenesis is complete, however, the exact gestational age that chemotherapy can be administered safely and avoid causing congenital malformations remains unknown.

AB - Chemotherapy puts a developing fetus at risk of teratogenic effects. The standard recommendation is that chemotherapy be administered after organogenesis is complete, however, the exact gestational age that chemotherapy can be administered safely and avoid causing congenital malformations remains unknown.

UR - http://www.scopus.com/inward/record.url?scp=85122744765&partnerID=8YFLogxK

U2 - 10.1097/01.ogx.0000802680.45004.84

DO - 10.1097/01.ogx.0000802680.45004.84

M3 - Comment/Letter to the editor

AN - SCOPUS:85122744765

VL - 76

SP - 732

EP - 733

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

SN - 0029-7828

IS - 12

ER -

Association of Chemotherapy Timing in Pregnancy With Congenital Malformation

Abstract

Access to Document

Other files and links

Fingerprint

Cite this